KENDRA LOWING: Open Payments
NPI 1710951488 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$116 in 5 payments from 5 companies in 2025. Trend: 2023 $69 · 2024 $53 · 2025 $116
Food & beverage: $116
| Company | Payments | Amount |
|---|---|---|
| Grifols USA, LLC | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $30 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $20 |
| Insmed, Inc. | 1 | $15 |
Products named: Prolastin-C Liquid, FASENRA, JASCAYD, NUCALA, Arikayce.
Industry payments across MI — which companies pay providers there.
